Tren/Test 350 mg is an oil-based injectable blend of Testosterone Enanthate and Trenbolone Enanthate manufactured by Dragon Pharma and dosed at 350 mg/mL in a 10 mL vial.
Tren/Test 350 mg combines two long-acting enanthate esters in a single injectable formulation: testosterone enanthate (200 mg/mL) and trenbolone enanthate (150 mg/mL). This blend is designed for non-medical body recomposition and mass-building applications, where the complementary properties of both compounds are commonly referenced together. Testosterone enanthate is an FDA-approved ester for testosterone replacement therapy in adult males with conditions associated with a deficiency or absence of endogenous testosterone. Trenbolone enanthate is a synthetic anabolic-androgenic steroid that belongs to the nandrolone group and is classified as an anabolic agent.
Each component contributes distinct pharmacological characteristics to the blend. Testosterone enanthate serves as the foundational anabolic hormone, supporting muscle protein synthesis, nitrogen retention, and maintenance of normal male physiological function. Trenbolone enanthate has the longest duration of action among trenbolone esters, with a half-life of approximately 11 days. It is a heavily modified 19-nortestosterone derivative characterized by its profound anabolic efficiency and resistance to both aromatization and 5α-reduction. Trenbolone enanthate is used mainly as an anabolic agent in veterinary practice and is not approved for human use. Both esters provide sustained release and typically require injections once or twice per week.
Combining two anabolic steroids in a single injectable introduces compounded cardiovascular and androgenic stress. Testosterone enanthate can increase blood pressure, which can increase cardiovascular risk over time. Trenbolone has been associated with significant lipid profile alterations and published case reports of severe liver injury. Both compounds suppress endogenous testosterone production, and the combination may produce more pronounced suppression than either compound alone. Forum discussions reference dosages of 200-500 mg trenbolone enanthate weekly alongside 300-500 mg testosterone enanthate weekly for body recomposition or bulking purposes. Non-medical use of Tren/Test 350 mg falls outside approved indications and may carry substantial health risks.
Tren/Test 350 mg uses MCT oil as its carrier, providing an oil base for the dual-ester blend. The 350 mg/mL total concentration delivers 200 mg of testosterone enanthate and 150 mg of trenbolone enanthate per mL.
Tren/Test 350 mg is a dual-ester blend combining two anabolic steroids with distinct pharmacological profiles. Both compounds are esterified with the enanthate chain, providing sustained release over days to weeks.
Testosterone enanthate is a long-acting testosterone ester indicated for testosterone replacement therapy in adult males with hypogonadism. The enanthate ester slows the release of testosterone from the injection site, producing a sustained duration of action. Once released, testosterone aromatizes to estradiol, which can contribute to water retention and estrogenic effects. Testosterone can increase blood pressure, and the FDA label states it is not recommended for use in men with uncontrolled hypertension.
Trenbolone enanthate is the longest-acting ester of trenbolone, with a half-life of approximately 11 days. It is a 19-nor compound with potent anabolic and androgenic activity. Trenbolone does not aromatize to estrogen, which distinguishes it from testosterone. It is classified as an anabolic agent that stimulates the development of muscle mass, strength, and power. Trenbolone enanthate is used mainly as an anabolic agent in veterinary practice and is not approved for human use.
The combination of testosterone and trenbolone in a single injectable is commonly referenced in non-medical bodybuilding contexts for its complementary effects. Testosterone provides the anabolic foundation and maintains normal physiological function, while trenbolone contributes potent recomposition effects. However, both compounds suppress endogenous testosterone production, and the combination may produce more pronounced suppression than either alone.
Both compounds in Tren/Test 350 mg are esterified with the enanthate chain. Trenbolone enanthate has the longest duration of action among trenbolone esters, with a half-life of approximately 11 days, while testosterone enanthate has a half-life of approximately 8 days. In non-medical contexts, the blend is typically referenced as being administered once or twice per week. Forum discussions reference weekly dosages ranging from 200-500 mg trenbolone enanthate alongside 300-500 mg testosterone enanthate for 10-16 week cycles. The extended release means that clearance of both compounds takes several weeks after discontinuation.
Dragon Pharma offers individual preparations of each component for users who prefer to control dosing separately. Trenbolone 200 provides trenbolone enanthate at 200 mg/mL as a standalone product, while Enantat 250 provides testosterone enanthate at 250 mg/mL. For those seeking a triple-compound blend, Superbolan 400 combines trenbolone enanthate, testosterone enanthate, and drostanolone enanthate.
The primary advantage of Tren/Test 350 mg is convenience: a single injection delivers both compounds in a fixed ratio. However, this fixed ratio means individual dosing adjustments are not possible without additional standalone products. Users who require different ratios of the two compounds may prefer to combine individual preparations. Aromatase inhibitors such as anastrozole are commonly referenced in non-medical contexts when the testosterone component produces estrogenic effects.
Published laboratory reports for Tren/Test 350 mg are shown below with the test date, measured concentration and percentage of the product's label claim for each component.
View Report
View Report
Laboratory results apply to the specific tested sample represented in each published report and should not be interpreted as a measurement of every vial or production batch.
The information below is provided for educational reference only. This product contains compounds that are not approved for human use in the United States; non-medical use falls outside any approved indications and carries substantial health risks.
In non-medical bodybuilding contexts, Tren/Test 350 mg is commonly referenced in the range of 1–2 mL per week, which delivers 350–700 mg total active compounds per week. This equates to 200–400 mg testosterone enanthate and 150–300 mg trenbolone enanthate per week. Forum discussions reference dosages ranging from 200-500 mg trenbolone enanthate weekly alongside 300-500 mg testosterone enanthate weekly for 10-16 week cycles. The 350 mg/mL concentration means that 1 mL provides 350 mg of total active compounds (200 mg testosterone enanthate and 150 mg trenbolone enanthate).
| Use Case | Common Reference Range | Injection Frequency |
|---|---|---|
| Beginner (non-medical) | 1 mL / week | Once weekly |
| Intermediate (non-medical) | 1.5–2 mL / week | Split into two injections |
| Advanced (non-medical) | 2–3 mL / week | Split into two injections |
In non-medical bodybuilding contexts, Tren/Test 350 mg is commonly referenced as a standalone blend, as it already contains both a testosterone base and a trenbolone component. Adding additional injectable or oral anabolic steroids would compound the total androgenic load and increase cardiovascular and hepatic stress. The fixed ratio may not suit all users, and some may prefer to adjust individual compound ratios using standalone products such as Trenbolone 200 or Enantat 250.
Cycle lengths of 10–16 weeks are commonly referenced for enanthate-based blends in non-medical contexts. The extended release profile of both esters means that clearance after the final injection takes several weeks. Trenbolone is known for producing pronounced side effects that may limit cycle length for many users.
Each component of Tren/Test 350 mg carries its own side effect profile. Testosterone enanthate can increase blood pressure, which can increase cardiovascular risk over time. It can also increase hematocrit and may cause gynecomastia. Aromatase inhibitors are commonly referenced for managing estrogenic effects.
Trenbolone is associated with significant cardiovascular effects, including lipid profile alterations, and published case reports have documented severe liver injury. Reported side effects include insomnia, night sweats, increased aggression, and mood disturbances. Hair loss is also commonly reported. Prolactin elevation is a recognized concern with 19-nor compounds. The combined cardiovascular and androgenic stress of both compounds used together has not been evaluated in controlled clinical trials.
After completing a cycle with Tren/Test 350 mg, post-cycle therapy is commonly recommended in non-medical contexts to help restore endogenous testosterone production. Both component compounds suppress natural testosterone production. Because of the enanthate esters, PCT should begin approximately 2 weeks after the final injection to allow the esters to clear. Agents such as Clomid or Nolvadex are frequently referenced for this purpose. Bloodwork and, where possible, medical guidance can help inform recovery strategy.
Dosing strategies, support compounds and recovery protocols should be adjusted based on experience level and bloodwork where possible. The information above is for educational reference and does not constitute medical advice.
Tren/Test 350 mg contains testosterone enanthate and trenbolone enanthate. Testosterone enanthate is FDA-approved as an individual medication; trenbolone enanthate is not approved for human use. The combination has not been evaluated in controlled clinical trials.
Testosterone enanthate is indicated for testosterone replacement therapy in adult males with hypogonadism. However, it has not been shown to be safe and effective for athletic performance enhancement, and the FDA label states it should not be used for such purpose. Trenbolone enanthate is used mainly as an anabolic agent in veterinary practice and is not approved for human use. Non-medical use of this combination falls outside any approved indication.
Use of Tren/Test 350 mg for bodybuilding or performance enhancement falls outside approved medical indications. The combination of two anabolic steroids introduces compounded cardiovascular and androgenic stress that has not been studied in controlled human trials.
Testosterone enanthate can increase blood pressure, which can increase cardiovascular risk over time. In controlled clinical trials, hematocrit increased and hypertension were among the most commonly reported adverse reactions. Edema with or without congestive heart failure may occur in patients with preexisting cardiac, renal, or hepatic disease. Venous thromboembolic events, including deep vein thrombosis and pulmonary embolism, have been reported in patients using testosterone products.
Trenbolone is associated with significant lipid profile alterations, including decreased HDL and increased LDL. Published case reports have documented severe cholestatic liver injury following trenbolone use. Reported side effects include insomnia, night sweats, increased aggression, and mood disturbances. Hair loss is also commonly reported. Both compounds suppress endogenous testosterone production, and the combination may produce more pronounced suppression than either compound alone.
Testosterone products are contraindicated in men with carcinoma of the breast or known or suspected carcinoma of the prostate, and in women who are pregnant. Trenbolone is not approved for human use and should not be considered appropriate for any medical condition. Individuals with pre-existing cardiovascular disease, hepatic or renal impairment, or uncontrolled hypertension should exercise particular caution. Existing medical conditions should be discussed with a qualified healthcare professional before any consideration of use.
If Tren/Test 350 mg is used in any context, monitoring of blood pressure, hematocrit, lipid profiles, and liver function is important given the known effects of the component compounds. Medically supervised testosterone therapy typically involves periodic measurement of serum testosterone, hematocrit, and prostate-specific antigen (PSA). Bloodwork before, during, and after a cycle is commonly referenced as a risk-reduction strategy in non-medical bodybuilding contexts.
Keep the vial securely stored and protected from conditions that could compromise the product or container. Store at controlled room temperature and protect from light. Inspect the vial and solution before use and do not use a product that appears damaged, contaminated or otherwise abnormal.
Keep all medications and injectable products out of the reach of children. Follow the storage instructions provided with the product packaging.
Tren/Test 350 mg by Dragon Pharma is shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.
To verify your Tren/Test 350 mg product, use the security code on the vial label and cross-check it on the Dragon Pharma official site. Original Dragon Pharma packaging and batch-linked lab proof help reinforce product legitimacy.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Proper storage conditions help preserve formulation stability and overall product integrity throughout shelf life.
Store at controlled room temperature (15–25°C) and protect from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the oily formulation.
Keep the vial in its original packaging until use. Do not freeze. Before administration, inspect the solution and avoid use if it appears cloudy, discolored, contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices when administering the product.
Answers to common questions about Tren/Test 350 mg, the dual-compound testosterone/trenbolone blend, usage considerations, product strength and laboratory testing.
Tren/Test 350 mg contains testosterone enanthate and trenbolone enanthate. Testosterone enanthate is indicated for testosterone replacement therapy in adult males with hypogonadism. Trenbolone enanthate is used mainly as an anabolic agent in veterinary practice and is not approved for human use. In non-medical bodybuilding settings, this blend is commonly referenced for body recomposition and mass-building cycles, though such use falls outside approved indications.
Because both compounds use the enanthate ester, Tren/Test 350 mg is typically referenced as being administered once or twice per week in non-medical contexts. The 350 mg/mL concentration means that 1 mL provides 200 mg testosterone enanthate and 150 mg trenbolone enanthate.
In non-medical bodybuilding contexts, post-cycle therapy is commonly recommended after a cycle with Tren/Test 350 mg to help restore endogenous testosterone production. Both component compounds suppress natural testosterone production. Because of the enanthate esters, PCT should begin approximately 2 weeks after the final injection. Agents such as Clomid or Nolvadex are commonly referenced for this purpose.
Testosterone enanthate serves as the anabolic foundation, supporting muscle protein synthesis, nitrogen retention, and maintenance of normal male physiological function. It aromatizes to estradiol. Trenbolone enanthate is a 19-nor compound with potent anabolic and androgenic activity. It does not aromatize to estrogen, which distinguishes it from testosterone, and is classified as an anabolic agent that stimulates muscle mass, strength, and power.
Because both compounds use the enanthate ester, Tren/Test 350 mg releases gradually over several weeks. Trenbolone enanthate has the longest duration of action among trenbolone esters, with a half-life of approximately 11 days. In non-medical contexts, users commonly reference noticing effects after approximately 2-4 weeks, with full saturation occurring over 4-6 weeks of use.
There is no single blend that is universally best for body recomposition. Tren/Test 350 mg combines two compounds with different properties in a fixed ratio. This ratio may not suit all users or goals. The individual preparations Trenbolone 200 and Enantat 250 are also referenced, either alone or in customized combinations. Forum discussions indicate that some users find trenbolone more suitable for cutting or recomposition than for traditional bulking.
Superbolan 400 contains trenbolone enanthate, testosterone enanthate, and drostanolone enanthate at a total concentration of 400 mg/mL. Tren/Test 350 mg contains only testosterone enanthate and trenbolone enanthate at 350 mg/mL. Superbolan 400 adds drostanolone for additional hardening and anti-estrogenic effects.
A milligram amount cannot be classified as appropriate or excessive without considering the specific context, individual response, and other factors. In non-medical bodybuilding contexts, forum discussions reference weekly dosages ranging from 200-500 mg trenbolone enanthate alongside 300-500 mg testosterone enanthate for 10-16 week cycles. The combination of two anabolic steroids introduces compounded cardiovascular and androgenic stress that has not been evaluated in controlled trials.
Tren/Test 350 mg is labeled at 350 mg of total active compounds per mL, comprising 200 mg testosterone enanthate and 150 mg trenbolone enanthate per mL. It is supplied in a 10 mL vial, giving 3,500 mg of total labeled content per vial.
Yes. A published laboratory report dated March 20, 2026 measured Tren/Test 350 mg at 100.13 mg trenbolone enanthate and 252.11 mg testosterone enanthate, equivalent to 66.75% and 126.06% of label claim respectively.
The complete report can be viewed in the Lab Reports tab. Laboratory results apply to the tested sample represented by the individual report and should not be interpreted as a measurement of every vial.
Tren/Test 350 mg combines two anabolic steroids, each with its own risk profile. Testosterone can increase blood pressure, which can increase cardiovascular risk over time. Trenbolone is associated with significant lipid profile alterations, published case reports of severe liver injury, and reported side effects including insomnia, night sweats, and increased aggression. Both compounds suppress endogenous testosterone production, and the combination may produce more pronounced suppression than either compound alone. The combined cardiovascular and androgenic stress of using both compounds together has not been evaluated in controlled clinical trials.
Yes. Testosterone and trenbolone are both prohibited substances in sport and can be detected in urine. The enanthate esters have relatively long detection times due to their prolonged release profile. Trenbolone enanthate in particular has a half-life of approximately 11 days. Athletes subject to drug testing should be aware that positive tests can result in sanctions.